Table 1.
Screening | Va | Follow up | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day | -10 | -3 | 0 | 1 | 2 | 3 | 4 | 7 | 14 | 21 | 30 | 45 | 60 | 90 | 120 | 150 | 180 |
Clinical evaluation | x | x | x | x | x | x | x | x | x | x | x | x | |||||
Informed Consent | x | ||||||||||||||||
Transmissibility samples | x | x | x | ||||||||||||||
Immunogenicity samples | x | x | x | x | x | x | |||||||||||
Adverse Events report | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
*Va=Vaccination.